Sinsin Pharmaceutical Statistics

Total Valuation

Sinsin Pharmaceutical has a market cap or net worth of KRW 79.65 billion. The enterprise value is 123.32 billion.

Market Cap	79.65B
Enterprise Value	123.32B

Important Dates

The last earnings date was Wednesday, November 13, 2024.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Sinsin Pharmaceutical has 15.17 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	15.17M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	51.50%
Owned by Institutions (%)	n/a
Float	7.26M

Valuation Ratios

The trailing PE ratio is 19.70.

PE Ratio	19.70
Forward PE	n/a
PS Ratio	0.76
PB Ratio	1.24
P/TBV Ratio	n/a
P/FCF Ratio	153.20
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.09, with an EV/FCF ratio of 237.22.

EV / Earnings	30.46
EV / Sales	1.17
EV / EBITDA	12.09
EV / EBIT	20.35
EV / FCF	237.22

Financial Position

The company has a current ratio of 0.93, with a Debt / Equity ratio of 0.70.

Current Ratio	0.93
Quick Ratio	0.63
Debt / Equity	0.70
Debt / EBITDA	4.38
Debt / FCF	86.04
Interest Coverage	2.98

Financial Efficiency

Return on equity (ROE) is 6.30% and return on invested capital (ROIC) is 3.53%.

Return on Equity (ROE)	6.30%
Return on Assets (ROA)	2.98%
Return on Capital (ROIC)	3.53%
Revenue Per Employee	311.38M
Profits Per Employee	11.98M
Employee Count	338
Asset Turnover	0.83
Inventory Turnover	4.55

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -23.58% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-23.58%
50-Day Moving Average	6,067.00
200-Day Moving Average	6,027.60
Relative Strength Index (RSI)	37.57
Average Volume (20 Days)	132,320

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sinsin Pharmaceutical had revenue of KRW 105.25 billion and earned 4.05 billion in profits. Earnings per share was 266.49.

Revenue	105.25B
Gross Profit	34.76B
Operating Income	6.06B
Pretax Income	4.24B
Net Income	4.05B
EBITDA	10.20B
EBIT	6.06B
Earnings Per Share (EPS)	266.49

Full Income Statement

Balance Sheet

The company has 790.23 million in cash and 44.73 billion in debt, giving a net cash position of -43.94 billion or -2,896.37 per share.

Cash & Cash Equivalents	790.23M
Total Debt	44.73B
Net Cash	-43.94B
Net Cash Per Share	-2,896.37
Equity (Book Value)	64.14B
Book Value Per Share	4,245.30
Working Capital	-4.14B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.45 billion and capital expenditures -2.93 billion, giving a free cash flow of 519.87 million.

Operating Cash Flow	3.45B
Capital Expenditures	-2.93B
Free Cash Flow	519.87M
FCF Per Share	34.27

Full Cash Flow Statement

Margins

Gross margin is 33.03%, with operating and profit margins of 5.76% and 3.85%.

Gross Margin	33.03%
Operating Margin	5.76%
Pretax Margin	4.03%
Profit Margin	3.85%
EBITDA Margin	9.69%
EBIT Margin	5.76%
FCF Margin	0.49%

Dividends & Yields

This stock pays an annual dividend of 60.00, which amounts to a dividend yield of 1.14%.

Dividend Per Share	60.00
Dividend Yield	1.14%
Dividend Growth (YoY)	20.00%
Years of Dividend Growth	2
Payout Ratio	22.48%
Buyback Yield	n/a
Shareholder Yield	1.14%
Earnings Yield	5.08%
FCF Yield	0.65%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Sinsin Pharmaceutical has an Altman Z-Score of 2.23. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.23
Piotroski F-Score	n/a